Fund HoldingsAtlas Venture Life Science Advisors, LLC

Total Portfolio Value
$865.15M
Total Bought
$4.70M
Total Sold
$146.30M
Net Transaction
-$141.59M
Filing Period:
Securities
SharesValue ($K)
Q3 2025
Q4 2025
Change
Q3 2025
Q4 2025
Weight (%)
Change
Kymera Therapeutics, Inc.(KYMR)4,896,4624,659,874-236,588277,140362,58541.91%+85,445
Dyne Therapeutics, Inc.(DYN)9,130,4659,130,4650115,500178,59220.64%+63,092
Sionna Therapeutics, Inc.(SION)3,615,5272,995,602-619,925106,333123,23914.24%+16,906
Day One Biopharmaceuticals, Inc.
COM
6,430,2576,412,560-17,69745,33359,7656.91%+14,432
Generation Bio, Co.0827,946+827,94604,7030.54%+4,703
Q32 Bio, Inc.2,092,1062,092,10604,1426,9460.80%+2,803
ImageneBio, Inc.377,8140-377,8143,0790-3,079
Generation Bio, Co.827,9460-827,9465,0670-5,067
Disc Medicine, Inc.(IRON)2,142,6171,513,875-628,742141,584120,21713.90%-21,367
Korro Bio, Inc.1,137,1491,137,149054,4589,1091.05%-45,350
Page 1 of 1